Patient preferences for

oral versus intravenous

palliative chemotherapy
G Liu, E Franssen, MI Fitch and
E Warner
Division of Oncology, Toronto
Sunnybrook Regional Cancer
Anggota kelompok;;
1.Daharani
Centre, Canada.r
2.Muhammad
3.Fauzil Ansyori
4.Faisal
5.Erwin
 PURPOSE:

To assess patient preference for oral

versus intravenous (i.v.) palliative
chemotherapy (CT).
A strong preference would be an
important quality-of-life issue.
 Patient and Method;
A structured interviewer-
administered scenario-based
questionnaire evaluated incurable
cancer patients who would be likely
to receive palliative CT in the future.
Using probability trade-offs, the
preference for route of administration
was evaluated against diminishing
treatment response.
RESULT:
Of 103 assessable patients
92 preferred oral CT,
10 preferred i.v. CT, and
One had no preference.

Of retain their initial preference

70% of patients were not willing to
accept a lower response rate
74% were not willing to accept a
shorter duration of response
99% of 39% wanted the specific
treatment decision
patients made primarily by their
had a physicians
prefere 38% primarily by
nce themselves

22% shared equally.

 Conclusion
Patients with incurable cancer
have a clear preference for oral
CT, but are generally not willing
to sacrifice efficacy for their
preference.
 Important message
Pasien harus mendapat informasi
yang adekuat
Pasien menginginkan pengobatan
yang nyaman bagi mereka.
Pengobatan yang teruji secara klinis
yang dipilih pasien
Keputusan terbanyak tetap pada
dokter yang menangani. (40%)
 Perspektif manajer
Rumahsakit
Menyediakan informasi yang adekuat
dan dikomunikasikan dengan baik
Memperhatikan dan selalu
meningkatkan tingkat kenyamanan
pasien.
Memberikan layanan yang berdasar
bukti dan senantiasa mengikuti
perkembangan.